Arcus Biosciences is a clinical-stage, global biopharmaceutical company developing differentiated molecules and combination medicines for people with cancer.

Source: https://www.marketscreener.com/quote/stock/ARCUS-BIOSCIENCES-INC-42096830/news/Gilead-and-Arcus-Announce-Anti-TIGIT-Domvanalimab-Continues-to-Demonstrate-Consistent-Improvement-in-44034075/?utm_medium=RSS&utm_content=20230603

Arvinas, Inc, a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins.

Source: https://www.etfdailynews.com/2023/08/09/barclays-trims-arvinas-nasdaqarvn-target-price-to-39-00/

Bellerophon Therapeutics, Inc is a clinical-stage biopharmaceutical company, which engages in the development of products that address significant unmet medical needs in the treatment of cardiopulmonary diseases.

Source: https://www.americanbankingnews.com/2023/01/27/bellerophon-therapeutics-inc-nasdaqblph-short-interest-up-1450-0-in-january.html

Benitec Biopharma Inc, a clinical-stage biotechnology company, focuses on the development of novel genetic medicines.

Source: https://www.etfdailynews.com/2023/12/09/benitec-biopharma-nasdaqbntc-stock-crosses-above-50-day-moving-average-of-3-35/

Cerevel Therapeutics Holdings, Inc, a clinical-stage biopharmaceutical company, develops various therapies for neuroscience diseases in the United States.

Source: https://www.americanbankingnews.com/2023/08/03/cerevel-therapeutics-nasdaqcere-price-target-lowered-to-41-00-at-hc-wainwright.html

Decibel Therapeutics, Inc, a clinical-stage biotechnology company, engages in discovering and developing transformative treatments for hearing and balance disorders.

Source: https://www.dailypolitical.com/2023/05/10/decibel-therapeutics-nasdaqdbtx-trading-down-0-9.html

Disc Medicine Opco Inc, together with its subsidiaries, operates as a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases.

Source: https://www.etfdailynews.com/2023/06/23/disc-medicine-opco-nasdaqiron-shares-gap-up-to-52-98/

Its development pipeline consists of clinical-stage compounds for the treatment of acute exacerbations of asthma and COPD, progressive multiple sclerosis, methamphetamine addiction, neuropathic pain, asthma, interstitial cystitis, and solid tumor cancers.

Source: https://www.dailypolitical.com/2023/01/19/medicinova-inc-nasdaqmnov-short-interest-update.html

Palisade Bio, Inc, a clinical-stage biopharmaceutical company, focuses on focuses on developing therapeutics that protect the integrity of the intestinal barrier in the United States.

Source: https://www.dailypolitical.com/2023/07/14/palisade-bio-inc-nasdaqpali-short-interest-down-75-2-in-june.html

ReViral, a clinical-stage biopharma company, is focused on developing antiviral therapeutics to curb the respiratory syncytial virus (RSV), which majorly affects babies and elders.

Source: https://www.ibtimes.com.au/pfizer-eyes-seagen-takeover-more-30bn-full-list-pandemic-driven-acquisition-spree-1844589?utm_source=Public&utm_medium=Feed&utm_campaign=Distribution

This report is aimed at those investors speculating on clinical-stage assets.

Source: https://seekingalpha.com/article/4575322-poseida-buying-this-rally-playing-the-roche-car-t-collaboration?source=feed_all_articles

Wave Life Sciences (Nasdaq: WVE) is a clinical-stage RNA medicines company committed to delivering life-changing treatments for people battling devastating diseases.

Source: https://forextv.com/top-news/wave-life-sciences-reports-second-quarter-2023-financial-results-and-provides-business-update/

Zymeworks Inc, a clinical-stage biopharmaceutical company, discovers, develops, and commercializes biotherapeutics for the treatment of cancer.

Source: https://www.etfdailynews.com/2023/01/26/allspring-global-investments-holdings-llc-grows-position-in-zymeworks-inc-nysezyme/